ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Pulmonary Disease

Top Pulmonary Disease Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS SCHNEIDER M.D.

Pulmonary Disease

20,565

$1.1M

999
822 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 58%

$54
Average prescription price

Avg: $189

WILLIAM WOOLERY MD

Pulmonary Disease

12,873

$584K

568
494 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 58%

$45
Average prescription price

Avg: $189

JEFFREY HARRIS M.D.

Pulmonary Disease

9,433

$2.44M

924
727 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 58%

$259
Average prescription price

Avg: $189

BERNARD SHORE MD

Pulmonary Disease

6,650

$375K

495
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 58%

$56
Average prescription price

Avg: $189

CHUKIAT TANSUWAN MD

Pulmonary Disease

6,371

$302K

298
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 58%

$47
Average prescription price

Avg: $189

ANN ROMAKER M.D.

Pulmonary Disease

5,965

$1.52M

652
469 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 58%

$255
Average prescription price

Avg: $189

MARK WALD M.D.

Pulmonary Disease

5,493

$955K

581
439 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 58%

$174
Average prescription price

Avg: $189

JOSEPH SERIA M.D.

Pulmonary Disease

5,369

$274K

202
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 58%

$51
Average prescription price

Avg: $189

GARY SALZMAN M.D.

Pulmonary Disease

5,006

$334K

244
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 58%

$67
Average prescription price

Avg: $189

KIRK FLURY M.D.

Pulmonary Disease

4,681

$457K

269
210 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 58%

$98
Average prescription price

Avg: $189

ELBERT TRULOCK MD

Pulmonary Disease

4,612

$969K

177
65 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 58%

$210
Average prescription price

Avg: $189

ANTHONY SHEN MD

Pulmonary Disease

4,477

$1.02M

434
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 58%

$229
Average prescription price

Avg: $189

PRANAV PARIKH M.D.

Pulmonary Disease

4,214

$830K

404
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 58%

$197
Average prescription price

Avg: $189

DANIEL POTTS MD

Pulmonary Disease

4,198

$516K

460
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 58%

$123
Average prescription price

Avg: $189

LAWRENCE LAMPTON M.D.

Pulmonary Disease

3,969

$177K

246
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 58%

$45
Average prescription price

Avg: $189

S KIM MD

Pulmonary Disease

3,808

$475K

470
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$125
Average prescription price

Avg: $189

NAVID ZAIDI MD

Pulmonary Disease

3,715

$817K

268
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 58%

$220
Average prescription price

Avg: $189

KIRK NELSON D.O.

Pulmonary Disease

3,647

$1.73M

435
329 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 58%

$474
Average prescription price

Avg: $189

RAMSEY HACHEM MD

Pulmonary Disease

3,524

$632K

164
63 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 58%

$179
Average prescription price

Avg: $189

NADEEM AHMED M.D.

Pulmonary Disease

3,341

$427K

122
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 58%

$128
Average prescription price

Avg: $189

GEORGE REISZ M.D.

Pulmonary Disease

3,338

$173K

161
75 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 58%

$52
Average prescription price

Avg: $189

ROYAL EATON M.D.

Pulmonary Disease

3,152

$714K

400
253 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 58%

$226
Average prescription price

Avg: $189

GRACIA NABHANE M.D.

Pulmonary Disease

3,117

$493K

299
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 58%

$158
Average prescription price

Avg: $189

RICHARD SUMMA M.D.

Pulmonary Disease

3,022

$627K

311
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 58%

$207
Average prescription price

Avg: $189

HEMANT SHETH M.D., F.C.C.P.

Pulmonary Disease

3,005

$230K

372
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 58%

$77
Average prescription price

Avg: $189

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank